| Bextra®
injury Philadelphia
If
you are currently taking Bextra check with your doctor.
|
On April
7, 2005 the FDA announced that it has asked Pfizer, Inc.
to withdraw Bextra
from the market "because the overall risk versus
benefit profile for the drug is unfavorable." |
Bextra® is a non-steroidal anti-inflammatory drug
(NSAIDs), known as a COX-2 selective agent. It is
prescribed for inflammation and pain from arthritis or menstrual
cramping. Other drugs in this class include Celebrex® and
Vioxx®. Bextra® and Celebrex® are both marketed by
Pharmacia Corporation and Pfizer
and Vioxx® is manufactured by Merck.
Some doctors switched patients
from Vioxx® to Bextra® when Merck voluntarily removed it from the
market due studies showing an increased risk for heart attack
and stroke.
Bextra® has since added warnings
to it's box strengthening previous warnings about the risk of life-threatening
skin reactions and a new bolded warning contraindicating
it's use for patients undergoing coronary artery bypass surgery.
bextra
site map
Click
here to read the FDA questions and answers about strengthened warnings on Bextra®
boxes
http://www.fda.gov/cder/drug/infopage/bextra/bextraQA.htm
To report any unexpected
adverse or serious events associated with the use of Bextra®
contact the FDA MedWatch program at: 1-800-FDA-1088 or on the
Internet at http://www.fda.gov/medwatch/index.html
For
a free case evaluation from a Pennsylvania attorney, click here:
http://www.lawforum.net/areas/bextra/pennsylvania/
Munley,
Munley & Cartwright, P.C. is a Pennsylvania law office which
has breaking news and information about this lawsuit
http://www.munley.com/drugs/bextra.html
Autism
Education Materials!
|
